 Neutralization low molecular weight heparin polybrene prevents thromboxane release severe pulmonary hypertension awake sheep Protamine reversal heparin anticoagulation patients life-threatening acute pulmonary hypertension sheep model effect adverse cardiopulmonary reaction type heparin low molecular weight heparin unfractionated heparin type heparin antagonist polybrene protamine Protamine reversal low molecular weight heparin LMWH polybrene reversal unfractionated heparin increase plasma thromboxane levels threefold increase pulmonary vascular resistance pulmonary artery pressure decrease similar adverse reaction protamine reversal conventional unfractionated heparin polybrene mg/kg reversal LMWH mg/kg pulmonary hypertension pulmonary artery pressure mm Hg minute polybrene reversal LMWH mm Hg protamine reversal unfractionated heparin groups differ hypoxemia unchanged minutes polybrene decrease mm Hg minutes protamine acute release thromboxane arterial plasma thromboxane minute polybrene ng/ml minute protamine hemodynamic effects mediator release benign neutralization doses LMWH mg/kg polybrene mg/kg increases activated clotting time partial thromboplastin time due types heparin polybrene Anti-Xa activity IU/ml minutes LMWH anticoagulation polybrene Various polyanion-polycation complexes heparin anticoagulation induce thromboxane release acute pulmonary vasoconstriction awake sheep Reversal LMWH anticoagulation polybrene adverse reaction